Xiujie Kong

Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status

Xiaoyang Li, Yuri K. Peterson, Elizabeth S. Inks et al. · Journal of Medicinal Chemistry · 2018 · 83 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant

Vasanthanathan Poongavanam, Dongwei Kang, Chiara Bertagnin et al. · Journal of Medicinal Chemistry · 2018 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant

N. Arul Murugan, Ye Tian, Chiara Bertagnin et al. · Journal of Medicinal Chemistry · 2018 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification of C5-NH₂ Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability

Han Ju, N. Arul Murugan, Lingxin Hou et al. · Journal of Medicinal Chemistry · 2021 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry

Jiangying Cao, Chunhua Ma, Jie Zang et al. · Bioorganic & Medicinal Chemistry · 2018 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15